Publications by authors named "Markus Heil"

Claim this Profile
3
3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
Jean De Vry, Dirk Denzer, Elke Reissmueller, Maud Eijckenboom, Markus Heil

J Pharmacol Exp Ther· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
Johannes-Peter Stasch, Peter Schmidt, Cristina Alonso-Alija, Heiner Apeler, Klaus Dembowsky, Markus Heil

Br J Pharmacol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis